Literature DB >> 28316349

New synthetic routes to thyroid hormone analogs: d6-sobetirome, 3H-sobetirome, and the antagonist NH-3.

Andrew T Placzek1, Thomas S Scanlan1.   

Abstract

New synthetic routes for the preparation of isotopically labeled versions of thyroid hormone agonist sobetirome were developed using Knochel's iodine-magnesium exchange. A more efficient synthesis of the thyroid hormone antagonist NH-3 was developed from a common intermediate in the sobetirome route. Using the new synthetic routes, d6- and 3H-sobetirome were prepared for their use in studying biodistribution and the cellular uptake of sobetirome. The new route to NH-3 allows for a more rapid and efficient synthesis and provides access to an advanced intermediate to facilitate antagonist analog production in the final bond-forming synthetic step.

Entities:  

Keywords:  NH-3; sobetirome; thyroid hormone; thyromimetics

Year:  2015        PMID: 28316349      PMCID: PMC5354297          DOI: 10.1016/j.tet.2015.05.049

Source DB:  PubMed          Journal:  Tetrahedron        ISSN: 0040-4020            Impact factor:   2.457


  9 in total

1.  Rational design and synthesis of a novel thyroid hormone antagonist that blocks coactivator recruitment.

Authors:  Ngoc-Ha Nguyen; James W Apriletti; Suzana T Cunha Lima; Paul Webb; John D Baxter; Thomas S Scanlan
Journal:  J Med Chem       Date:  2002-07-18       Impact factor: 7.446

2.  Pd-C-induced catalytic transfer hydrogenation with triethylsilane.

Authors:  Pijus K Mandal; John S McMurray
Journal:  J Org Chem       Date:  2007-07-14       Impact factor: 4.354

3.  A selective thyroid hormone β receptor agonist enhances human and rodent oligodendrocyte differentiation.

Authors:  Emily G Baxi; Jason T Schott; Amanda N Fairchild; Leslie A Kirby; Rabia Karani; Prech Uapinyoying; Carlos Pardo-Villamizar; Jeffrey R Rothstein; Dwight E Bergles; Peter A Calabresi
Journal:  Glia       Date:  2014-05-24       Impact factor: 7.452

4.  The thyroid hormone receptor-beta-selective agonist GC-1 differentially affects plasma lipids and cardiac activity.

Authors:  S U Trost; E Swanson; B Gloss; D B Wang-Iverson; H Zhang; T Volodarsky; G J Grover; J D Baxter; G Chiellini; T S Scanlan; W H Dillmann
Journal:  Endocrinology       Date:  2000-09       Impact factor: 4.736

5.  Improved synthesis of the iodine-free thyromimetic GC-1.

Authors:  G Chiellini; N H Nguyen; H A Yoshihara; T S Scanlan
Journal:  Bioorg Med Chem Lett       Date:  2000-12-04       Impact factor: 2.823

6.  Suppressing thyroid hormone signaling preserves cone photoreceptors in mouse models of retinal degeneration.

Authors:  Hongwei Ma; Arjun Thapa; Lynsie Morris; T Michael Redmond; Wolfgang Baehr; Xi-Qin Ding
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

7.  Induction of the adrenoleukodystrophy-related gene (ABCD2) by thyromimetics.

Authors:  Emmanuelle C Genin; Catherine Gondcaille; Doriane Trompier; Stéphane Savary
Journal:  J Steroid Biochem Mol Biol       Date:  2009-05-03       Impact factor: 4.292

8.  A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor.

Authors:  G Chiellini; J W Apriletti; H A Yoshihara; J D Baxter; R C Ribeiro; T S Scanlan
Journal:  Chem Biol       Date:  1998-06

Review 9.  Sobetirome: a case history of bench-to-clinic drug discovery and development.

Authors:  Thomas S Scanlan
Journal:  Heart Fail Rev       Date:  2008-11-11       Impact factor: 4.214

  9 in total
  11 in total

1.  Sobetirome and its Amide Prodrug Sob-AM2 Exert Thyromimetic Actions in Mct8-Deficient Brain.

Authors:  Soledad Bárez-López; Meredith D Hartley; Carmen Grijota-Martínez; Thomas S Scanlan; Ana Guadaño-Ferraz
Journal:  Thyroid       Date:  2018-06-29       Impact factor: 6.568

2.  Increasing Thyromimetic Potency through Halogen Substitution.

Authors:  Jordan Devereaux; Skylar J Ferrara; Tania Banerji; Andrew T Placzek; Thomas S Scanlan
Journal:  ChemMedChem       Date:  2016-10-12       Impact factor: 3.466

3.  Targeting Fatty-Acid Amide Hydrolase with Prodrugs for CNS-Selective Therapy.

Authors:  J Matthew Meinig; Skylar J Ferrara; Tania Banerji; Tapasree Banerji; Hannah S Sanford-Crane; Dennis Bourdette; Thomas S Scanlan
Journal:  ACS Chem Neurosci       Date:  2017-08-18       Impact factor: 4.418

4.  Pharmacological Complementation Remedies an Inborn Error of Lipid Metabolism.

Authors:  Meredith D Hartley; Mitra D Shokat; Margaret J DeBell; Tania Banerji; Lisa L Kirkemo; Thomas S Scanlan
Journal:  Cell Chem Biol       Date:  2020-03-12       Impact factor: 8.116

5.  Sobetirome prodrug esters with enhanced blood-brain barrier permeability.

Authors:  Andrew T Placzek; Skylar J Ferrara; Meredith D Hartley; Hannah S Sanford-Crane; J Matthew Meinig; Thomas S Scanlan
Journal:  Bioorg Med Chem       Date:  2016-09-16       Impact factor: 3.641

6.  Ester-to-amide rearrangement of ethanolamine-derived prodrugs of sobetirome with increased blood-brain barrier penetration.

Authors:  Skylar J Ferrara; J Matthew Meinig; Andrew T Placzek; Tapasree Banerji; Peter McTigue; Meredith D Hartley; Hannah S Sanford-Crane; Tania Banerji; Dennis Bourdette; Thomas S Scanlan
Journal:  Bioorg Med Chem       Date:  2017-03-23       Impact factor: 3.641

7.  Myelin repair stimulated by CNS-selective thyroid hormone action.

Authors:  Meredith D Hartley; Tania Banerji; Ian J Tagge; Lisa L Kirkemo; Priya Chaudhary; Evan Calkins; Danielle Galipeau; Mitra D Shokat; Margaret J DeBell; Shelby Van Leuven; Hannah Miller; Gail Marracci; Edvinas Pocius; Tapasree Banerji; Skylar J Ferrara; J Matthew Meinig; Ben Emery; Dennis Bourdette; Thomas S Scanlan
Journal:  JCI Insight       Date:  2019-04-18

8.  A Thyroid Hormone-Based Strategy for Correcting the Biochemical Abnormality in X-Linked Adrenoleukodystrophy.

Authors:  Meredith D Hartley; Lisa L Kirkemo; Tapasree Banerji; Thomas S Scanlan
Journal:  Endocrinology       Date:  2017-05-01       Impact factor: 4.736

9.  TREM2 is thyroid hormone regulated making the TREM2 pathway druggable with ligands for thyroid hormone receptor.

Authors:  Skylar J Ferrara; Priya Chaudhary; Margaret J DeBell; Gail Marracci; Hannah Miller; Evan Calkins; Edvinas Pocius; Brooke A Napier; Ben Emery; Dennis Bourdette; Thomas S Scanlan
Journal:  Cell Chem Biol       Date:  2021-08-09       Impact factor: 8.116

10.  Investigation of NH3 as a selective thyroid hormone receptor modulator in larval zebrafish (Danio rerio).

Authors:  Kyla M Walter; Latika Singh; Vikrant Singh; Pamela J Lein
Journal:  Neurotoxicology       Date:  2021-03-18       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.